Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Proteolytic enzymes damage hair follicles by detaching stem cells.

Improved nutrition quickly healed the patient's skin lesions.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

GLI2 activates GLI1, promoting skin tumor growth and hair development.

Glycine reduces skin pigmentation by lowering melanin production.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

NUL-5 may boost hair growth by improving hair follicle health and structure.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Cathepsin L deficiency causes large, abnormal cell structures and health issues in mice.

The role of γδT-cells in causing alopecia areata remains unclear.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

The study created a mouse model that survives longer and shows fewer symptoms of pemphigus vulgaris.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Introducing the rat OTC gene partially corrected OTC deficiency in mice.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

A genetic variant in goats is linked to cashmere growth.

The patient had paraneoplastic pemphigus without mucosal involvement.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.